Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
NCT00238407
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
Docetaxel and Cisplatin
RADIATION:
Radiotherapy
Sponsor
Swiss Cancer Institute